Headlines about Danaher (NYSE:DHR) have been trending somewhat positive this week, Accern reports. Accern ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Danaher earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned news coverage about the conglomerate an impact score of 46.5177929579219 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the news articles that may have impacted Accern’s rankings:
Danaher (NYSE:DHR) traded up $0.82 during midday trading on Friday, hitting $100.56. 2,278,162 shares of the company traded hands, compared to its average volume of 2,250,000. The company has a current ratio of 1.43, a quick ratio of 1.00 and a debt-to-equity ratio of 0.42. The company has a market cap of $69,950.00, a P/E ratio of 29.93, a P/E/G ratio of 2.16 and a beta of 1.03. Danaher has a fifty-two week low of $78.97 and a fifty-two week high of $100.88.
Danaher (NYSE:DHR) last released its earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The firm had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. Danaher had a net margin of 13.36% and a return on equity of 11.29%. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.87 EPS. sell-side analysts anticipate that Danaher will post 3.99 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be paid a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a yield of 0.56%. The ex-dividend date of this dividend is Thursday, December 28th. Danaher’s payout ratio is currently 16.67%.
Several research firms have commented on DHR. Stifel Nicolaus reissued a “buy” rating and issued a $110.00 target price on shares of Danaher in a research report on Friday. Robert W. Baird reaffirmed a “buy” rating on shares of Danaher in a report on Friday, January 12th. Zacks Investment Research downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Credit Suisse Group reaffirmed a “hold” rating and set a $99.00 price objective on shares of Danaher in a report on Tuesday, December 19th. Finally, Royal Bank of Canada reaffirmed a “hold” rating and set a $96.00 price objective on shares of Danaher in a report on Thursday, January 4th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $95.86.
In related news, Director Donald J. Ehrlich sold 10,578 shares of the company’s stock in a transaction on Tuesday, October 24th. The shares were sold at an average price of $90.82, for a total transaction of $960,693.96. Following the completion of the transaction, the director now directly owns 104,621 shares in the company, valued at approximately $9,501,679.22. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Daniel Raskas sold 37,870 shares of the company’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total transaction of $3,534,407.10. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 273,810 shares of company stock valued at $25,218,813. Corporate insiders own 12.20% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This story was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.dispatchtribunal.com/2018/01/19/danaher-dhr-receives-daily-news-impact-score-of-0-21.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.